Default Theme
AIIMS NEW
अखिल भारतीय आयुर्विज्ञान संस्थान, नई दिल्ली
All India Institute Of Medical Sciences, New Delhi
कॉल सेंटर:  011-26589142

DR. AJAY GOGIA

 

Curriculum Vitae

Dr. Ajay Gogia, MD, DM, is an Associate Professor in the Department of Medical Oncology at Dr. B.R.A Institute-Rotary Cancer Hospital All India Institute of Medical Sciences (AIIMS), New Delhi, India. He received his  M.B.B.S, MD (Internal Medicine) degree from Banaras Hindu University, DM (Medical Oncology) from AIIMS, New Delhi. He has over 15 year of working and teaching experience in Medical Oncology and specializes Breast Cancer ,Non-Hodgkin’s Lymphoma and Chronic lymphocytic leukemia. He has gained  his  International exposure  in Europe , North America , UK and Canada. His research is well published with more than 300 peer reviewed articles in National and International oncology journals and is well cited.  His letters and correspondence are well accepted  and published in reputed  journals ( NEJM, Lancet Oncology and JAMA Oncology). He has received Dronacharya Award and Golden aim Award  in the field of Oncology for his excellence

 

Name                                                    :                   Dr. Ajay Gogia

 

Qualifications                                         :                   MBBS,

                                                                                MD (Internal Medicine),

                                                                                DM (Medical Oncology)

 

Current Appointment                                                  Additional Professor

                                                                                Department of Medical Oncology,

                                                                                Dr. B.R.A, I.R.C.H,

                                                                                All India Institute of Medical Sciences (AIIMS)

                                                                                Ansari Nagar, New Delhi, 110029

 

Nationality                                              :                   Indian

 

Education and Qualifications

 

Degree

University

Year

MBBS

Institute of Medical Sciences, Banaras Hindu University, Varanasi-India

2000

M.D.(Internal Medicine)

Institute of Medical Sciences, Banaras Hindu University, Varanasi-India

2003

D.M. (Medical Oncology)

All India Institute of Medical Sciences(AIIMS),

New Delhi, India

2011

 

Working place and post  

Post

University/ INSTITUTE

Year

Senior Residency and

D.M ( Medical Oncology)

All India Institute of Medical Sciences (AIIMS),

 New Delhi, India

2006-11

Senior Research Associate

(Pool Officer)

All India Institute of Medical Sciences(AIIMS), New Delhi, India

2011-12

Assistant Professor

All India Institute of Medical Sciences(AIIMS), New Delhi, India

2013- 2016

Associate Professor

All India Institute of Medical Sciences(AIIMS), New Delhi, India

2017- 2019

Additional Professor

All India Institute of Medical Sciences(AIIMS), New Delhi, India

2020-till date

 

Working&TEACHING experienec in medical oncology: 15 years  

 Specific Area of Interest

OPD Schedule and timing

Member of the multidisciplinary teams of Breast cancer clinic (BCC) and lymphoma clinic at Dr. B.R.A-IRCH, All India Institute of Medical Sciences (AIIMS)and taking care of Medical Management of Breast cancer, B-cell Non Hodgkin lymphoma and Chronic  lymphocytic leukemia’s

Breast Cancer

 

Monday (2.00pm, Breast cancer clinic, Board Room).Wednesday and Friday (9.30 am, Adult Medical Oncology clinic, Board Room)

Non-Hodgkin Lymphoma  and Chronic lymphocytic leukemia  (CLL)

Thursday (9.30  am , LL clinic, Room No. 4), Wednesday and Friday (9.30 am, Adult Medical Oncology Clinic, Board Room)

 

 Fellowship

PLACE

Year

Indian American cancer Association-(IACA) Fellowship

Cleveland Clinic. OHIO, United States of America (USA)

Mentor: Prof. Jame Abraham

2016

European Society Of Medical Oncology (ESMO) Fellowship

Jules Bordet Hospital, Brussels

Mentor: Prof. Martine Piccart

2017

 

 MD Anderson Cancer center (MDACC)

MDACC, Houston, Texas,USA

Mentor :Prof. Hagop M.Kantarjian / Prof. Jain

2018

ESMO-  Palliative care fellowship

 

Princess Margaret Cancer Centre Toronto,Canada

Mentor : Prof. Subratha Banerjee

2019

 

Awards/Honors

PLACE

Year

Dronacharya-Award  in Oncology

New Delhi by  Minister of Health and welfare

2019

Golden Aim Award

New Delhi by Minister of Health and welfare

2022

International Best Poster Award

European Society of Medical Oncology , Barcelona, Spain

2019

Young Investigator Award

International Society of hematology and oncology

2022

Young Investigator Award

sAINTGALLEN BREAST CANCER Socity  switzereland

2013

Young Investigator Award

global Breast Cancer conference 2021

2021

 

International Oncology Research   scholarship/grant

PLACE

Year

American Association of Cancer Research (AACR)/Australia & Asia Pacific Clinical Oncology Research Development (ACORD)

Sydney, Australia

2018

INDOX Cancer Research Network

University of Oxford, United Kingdom ( UK)

2012

European Society Of Medical Oncology (ESMO)- Translational unit visit

Christie NHS Foundation Trust, Manchester, United Kingdom

( UK)

2012

European School of Oncology –Master class in clinical Oncology

Ermatingen, Switzerland

2012

 

 

 

 

 

 

 

Observer- ship 

PLACE

Year

ESO-Short term in-house observer ship

The Royal Marsden Hospital, London UK

2019

Short term in-house observer ship

Sarah Cannon Center, Nashville, USA

2017

Principle- Investigator ( PI)

 A Prospective, Multicentre, Phase-IV Clinical Trial of Olaparib in Indian Patients with Platinum Sensitive Relapsed Ovarian Cancer who are in Complete or Partial Response Following Platinum Based Chemotherapy and Metastatic Breast Cancer with Germline BRCA1/2 Mutation (SOLI Study)

A phase II randomized study of the combination of Ribociclib plus goserelin

acetate with Hormonal Therapy versus physician choice chemotherapy in premenopausal or perimenopausal patients with hormone receptor positive/HER2-negative inoperable locally  advanced or metastatic breast cancer - RIGHT Choice Study.

 Real world outcomES with ribOciclib in indiaNpATiEnts with HR+, HER2 -, Advanced Breast Cancer

(RESONATE)

Alpelisib India Safety Study (ALPINIST): a Phase IV, prospective, multicenter, open-label, non-comparative, interventional study to assess the safety of alpelisib plus fulvestrant, in men and post-menopausal women with HR-positive, HER2-negative, advanced breast cancer (aBC) with a PIK3CA mutation, whose disease has progressed on or after endocrine based treatment.

Co- Investigator ( CO-PI)

A Phase III, Randomized, Open-Label, Two-Arm Study of Neratinib Plus Paclitaxel Versus Trastuzumab Plus Paclitaxelas First Line Treatment for ErbB-2-Positive Locally Recurrent or Metastatic Breast Cancer.3144A2-3005-WW (Wyeth)

A Phase III, Randomized, Open-Label, Two-Arm Study of Neratinib Plus Paclitaxel Versus Trastuzumab Plus Paclitaxelas First Line Treatment for ErbB-2-Positive Locally Recurrent or Metastatic Breast Cancer.3144A2-3005-WW (Wyeth)

A Phase III, Open Label, Randomized Multicenter Trial of Ofatumumab-Chlorambucil combination Vs. ChlorambucilMonotherapy in previously untreated patients with Chronoic Lymphocytic Leukemia”. Protocol: OMB110911. 

OMB110913 - A Phase III, Open Label, Randomized Trial of Ofatumumab added to Fludarabine-Cyclophosphamide Vs. Fludarabine-Cyclophosphamide Combination in Subjects with Relapsed Chronic Lymphocytic Leukemia

EGF105485 (TEACH):A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjuvant Lapatinib in Women with Early-Stage ErbB2 Overexpressing Breast Cancer.

ATLAS (Adjuvant Tamoxifen Long Against Short): A major international trial funded by Oxford University, UK

A randomized, multi-center, open-label, phase III study of Adjuvant Lapatinib, Trastuzumab, their sequence and their combination in patients with HER2/ErbB2 positive primary breast cancer.” (ALTTO Study)

Axitinib (AG-013736) as second line therapy for metastatic renal cell cancer: axis trial. Sponsored by Pfizer.

A Study of TrastuzumabEmtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer (EMILIA)

A Multi Centre, Pilot Phase II Trial Assessing The Efficacy And Safety Of Bevacizumab + Gemcitabine + Carboplatin AsFirst Line Treatment For Patients Diagnosed With Triple Negative Metastatic Breast Cancer (Protocol No. ML 25420) 

Setting up Hospital Based Cancer Registries ( HBCRs)  and  Pattern of Care and Survival Studies on Breast Cancer

 

 

 

 

 

Others

CLINICAL PROJECT – AS A CO- INVESIGATOR with Different super/sub specialties in AIIMS (40 in number)

International scholarship/young investigator award to present oral presentation =5

DM-Medical Oncology Teaching curriculum &  Exam Coordinator: Since 2013

Active participation in teaching including MBBS/MD/DM/ MSc Nursing Student  

Active Participation in FREE Medical Camp organized by AIIMS or Govt. of India at LEH and DHARAMSHALA

Regular Participating in patient awareness programme in DOORDARSHAN & RAJSABHA TV

 

CURRENT MEMBERSHIPS IN PROFESSIONAL SOCIETIES  

  • Members in American Society of Clinical Oncology-(ASCO ID -10476)

  • European Society of Medical Oncology- ESMO-ID-(82716)

 

PUBLICATIONS: over 300 ( name highlighted)

 

PUBLICATIONS:

 

Rani L, Mathur N, Gogia A, Vishnubhatla S, Kumar L, Sharma A, Dube D, Kaur P, Gupta R.Immunoglobulin heavy chain variable region gene repertoire and B-cell receptor stereotypes in Indian patients with chronic lymphocytic leukemia.Leuk Lymphoma. 2016 Oct;57(10):2389-400

 

 

POSTER / ORAL PRESENTATION – abstracts  

 

  • Kumar R, Srivastava A, Agrawal U, Deo SV, Mathur SR, Gogia A, Tanwar P. Evaluation of mutation profile of oncogenic signalling pathway in breast cancer among Indian population. Cancer Research. 2022 Jun 15;82(12_Supplement):2277.

  • Gupta A, Gogia A, Sagiraju HK, Deo SV, Gupta R, Mathur S, Sharma D. A real-world experience of TCH (docetaxel/carboplatin/trastuzumab) regimen in early, locally advanced and oligometastatic HER2 positive breast cancer from tertiary care center in North India. J Clin Oncol 2022;40:e12505-e12505 .

  • Gogia A, Gupta A, Deo SV, Sharma D, Mathur S. Safety, efficacy and survival outcome of Ado-trastuzumab emtansine (T-DM1) in patients with metastatic HER2-positive breast cancer: An Indian experience. J Clin Oncol 2022;40:e13008-e13008.

  • Sharma RK, Gogia A, Sagiraju HK, Deo SS, Sharma D, Mathur S. Impact of capecitabine maintenance on survival outcomes in triple-negative breast cancer patients not attaining pathological complete response following neoadjuvant chemotherapy: Real-world data from a tertiary care center from India. J Clin Oncol 2022;40:e12593-e12593.

  • Batra A, kumar A, Pramanik R, Khurana S, Pushpam D, Bakhshi S, Sharma A, GogiaA,Malik PS. Physical and psychological symptom burden in patients newly diagnosed with solid organ cancers in a tertiary care centre in India. J Clin Oncol 2022;40:e24081-e24081.

  • Sharma RK, Gogia A, Sagiraju HK, Deo SS, Sharma D, Mathur S. Dose-dense neoadjuvant chemotherapy in triple-negative breast cancer: Real-world data from a developing country. J Clin Oncol 2022:40:e12594-e12594

  • Sagiraju HK, Gogia A, Sharma RK, Deo SV, Sharma D, Gupta R, Mathur S. Association of pre-treatment hemoglobin levels with survival outcomes among Indian women with triple negative breast cancer. J Clin Oncol 2022;40:e12549-e12549

  • Gupta A, Gogia A, Sagiraju HK, Deo SV, Sharma D, Mathur S, Gupta R. Outcomes of neoadjuvant combination chemotherapy with and without targeted therapy in HER2-positive breast cancer: A real-world experience from tertiary care center in North India. J Clin Oncol 2022;40:e12601-e12601 .

  • Gogia A, Sharma A, Gupta R, Rani L, Mallick S. Safety and efficacy of Ibrutinib in Indian patients with chronic lymphocytic leukemia. J Clin Oncol 2022;40:e19585-e19585

  • Das N, Gupta R, Dahiya M, Rai S, Singh S, Sahoo RK, Gogia A, Sharma A, Kumar L. MM-359: Pattern-Based Identification of Normal and Aberrant Plasma Cell Compartment across a Spectrum of Plasma Cell Proliferative Disorders Using Multiparametric Flow Cytometry. Clinical Lymphoma Myeloma and Leukemia. 2021 Sep 1;21:S438.

  • Gogia A, Kumar L, Sharma A, Mallick S, Gupta R, Rani L. CLL-069: Incidence of Second Cancer in Patients with Chronic Lymphocytic Leukemia: The Indian Scenario. Clinical Lymphoma, Myeloma and Leukemia. 2021 Sep 1;21:S316-7.

  • Jain S, Goswami A, Mandal T, Lone MR, Ramteke P, Sharma MC, Gogia A, Sharma A, Aggarwal M, Sahoo R, Bakhshi S. TCL-239: Clinical, Pathological, and Prognostic Implications of RHOAG17V Mutation in Peripheral T-Cell Lymphomas. Clinical Lymphoma, Myeloma and Leukemia. 2021 Sep 1;21:S413-4.

  • Gogia A, Chellapuram S, Sharma A, Mallick S, Gupta R. ABCL-064:“DA-EPOCH+/-R” Protocol in High-Grade Lymphoma: An Analysis. Clinical Lymphoma, Myeloma and Leukemia. 2021 Sep 1;21:S379-80.

  • Gupta R, Das N, Dahiya M, Rai S, Singh S, Prajapati VK, Gogia A, Sharma A, Kumar L. MM-329: Evaluation of Immunophenotype of the Non-Neoplastic Plasma Cell Compartment and Post-Therapy Immunomodulation to Understand Nuances in MRD Assessment of Multiple Myeloma Using Next-Generation Flow Cytometry. Clinical Lymphoma, Myeloma and Leukemia. 2021 Sep 1;21:S436-7.

  • Ramteke P, Jain S, Meena S, Mandai T, Das P, Yadav R, Sharma MC, Gogia A, Parmanik R, Sharma A, Bakhshi S. ABCL-321: Clinicopathological Profile of Gastrointestinal Lymphoma Diagnosed Over a Period of 6-Years: A Tertiary Care Center Experience. Clinical Lymphoma, Myeloma and Leukemia. 2021 Sep 1;21:S390-1.

  • harma A, Kumar S, Gogia A, Gupta R, Thulkar S, Pramanik R, Sharma MC, Raina V. Autologous Stem Cell Transplant in Non Hodgkin Lymphoma at Aiims: Trends in Tolerability And Long Term Outcomes. In Bone Marrow Transplantation 2021 Jun 1 (Vol. 56, No. Suppl 1, Pp. 279-280). Campus, 4 Crinan St, London, N1 9xw, England: Springernature.

  • Sharma RK, Gogia A, Deo SV, Sharma D, Mathur S, Sagiraju HK. Does pathological complete remission after neoadjuvant chemotherapy translate to longer relapse-free survival in patients with triple-negative breast cancer in the Indian population? J Clin Oncol. 2021;39:e12618-e12618.

  • Sagiraju HK, Gogia A, Sharma D, Deo SV, Mathur S. Survival outcomes of breast cancer patients with brain metastases: Single center experience from Northern India. J Clin Oncol. 2021 39:15_suppl, e13003-e13003

  • Gogia A, Arora S, Choudhary P, Kumar R, Thulkar S, Deo SV, Sharma D, Bhatnagar S. Real-world Indian scenario of CDK4/6 inhibitors (palbociclib and ribociclib) with endocrine therapy in upfront hormone positive metastatic breast cancer. J Clin Oncol 021 39:15_suppl, e13028-e13028.

  • Gogia A, Arora S, Deo SV, Mathur S, Sharma D. Efficacy and safety of neoadjuvantdocetaxel, carboplatin, trastuzumab, and pertuzumab (TCH-P) in HER2-positive breast cancer: An Indian experience. J Clin Oncol. 2021 39:15_suppl, e12619-e12619 Sharma RK, Gogia A, Gupta R, Deo SV, Sharma D, Mathur S, Sagiraju HK. Impact of pre-treatment derived neutrophil-lymphocyte-ratio on outcomes in patients with triple- negative breast cancer. J Clin Oncol 2021 39:15_suppl, e12556-e12556.

  • Atul Batra, Akhil P. Santosh, Raja Pramanik, Gogia A, R. M. Pandey, akashkumar, Atul SharmaRandomized double-blind, placebo-controlled study of topical diclofenac in prevention of hand-foot syndrome in patients receiving capecitabine. (ASCO 2021) J Clin Oncol 39, 2021 (suppl 15; abstr TPS12135)

  • Rakesh Kumar Sharma, Gogia A, SVS Deo, Dayanand Sharma, Sandeep Mathur, Hari Krishna Raju Sagiraju;Impact of pre-treatment derived neutrophil-lymphocyte-ratio on outcomes in patients with triple-negative breast cancer. J Clin Oncol 39, 2021 (suppl 15; abstr e13010)

  • K Raghuram, SVS Deo, Gogia A, S Thulkar, E Dhamija, DN Sharma, Analysis of surgical and oncological outcomes of breast conservation surgery following neo adjuvant chemotherapy in locally advanced breast cancer. European Journal of Surgical Oncology 46 (6), e31

  • SC Nair, Gogia A, L Kumar, A Sharma, A Biswas, S Mallick Clinicopathological features and outcome of diffuse large B-cell lymphoma patients treated in a resource-limited setting.Journal of Clinical Oncology 38 (15_suppl), e20062-e20062

  • Gogia A, S Nair, A Sharma, L Kumar, S Mallick, A Biswas, R Gupta Non-Hodgkin lymphoma: The Indian scene. Journal of Clinical Oncology 38 (15_suppl), e20063-e20063

  • Gogia A, S Deo, D Sharma, S Mathur. Breast cancer: The Indian scenario.Journal of Clinical Oncology 38 (15_suppl), e12567-e12567

  • SC Nair, Gogia A, L Kumar, A Sharma, A Biswas, S Mallick Clinicopathologic features and outcome of extra-nodal diffuse large B-cell lymphoma: An institutional experience from North India.Journal of Clinical Oncology 38 (15_suppl), e20079-e20079

  • P Choudhary, Gogia A, S Deo, S Mathur, D Sharma. Neoadjuvant chemotherapy in locally advanced breast cancer: Clinicopathological characteristics and correlation with pathological complete response.Journal of Clinical Oncology 38 (15_suppl), e12658-e12658

  • R Gupta, L Rani, G Kaur, S Khan, Gogia A, A Gupta, A Sharma, L KumarmiR-223 and miR-551a as gene signatures of aggressive chronic lymphocytic leukemia. Leukemia& Lymphoma 61, 206-207

  • S Mathur, A Johnson, SVS Deo, Gogia A, S Kahol, D Jain, V IyerPDL1 Expression and Tumour Infiltrating Lymphocytes in Triple-Negative Breast Cancer and its Correlation with Clinicopathological Features and Response to ChemotherapyLaboratory Investigation 100 (Suppl 1), 208-209

  • H Natarajan, L Kumar, S Bakhshi, A Sharma, T Velpandian, M Kabra, Gogia A.  Imatinib induced toxicity and its influence on cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia Annals of Oncology 201930   (Supplement_9), mdz427. 004

  • Gogia A, L Kumar, A Sharma, R Gupta, L Rani. Incidence and outcome of chronic lymphocytic leukemia with deletion 17p: An Indian experience; challenges and opportunities. Annals of Oncology 30 (Supplement_5), mdz269. 055

  • N Das, A Malhotra, R Gupta, S Rai, SK Gupta, RK Sahoo, Gogia A.  CD123 is an Important Predictor of Post Induction Response and Early Treatment Outcome in Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma and Leukemia 19, S197

  • S Mallick, A Panda, MR Lone, A Goswmi, P Ramteke, MC Sharma, GogiaA.ClinicopathologicalProfileof Primary Double Expressor Lymphoma. Clinical Lymphoma, Myeloma and Leukemia 19, S257

  • N Das, A Malhotra, R Gupta, S Rai, S Singh, RK Sahoo, Gogia A.Role of CD123 as Determinant of Minimal Residual Disease in Acute Myeloid Leukemia. Clinical Lymphoma, Myeloma and Leukemia 19, S235

  • Gogia A, R Gupta, A Sharma, L Kumar, V Raina, L Rani. Chronic lymphocytic leukemia: An Indian experience. Journal of Clinical Oncology 37 (15_suppl), e19007-e19007 2019

  • KR Soti, L Kumar, R Saxena, S Bakhshi, Gogia A, PS Malik, R Sahoo. Characteristics and outcomes of Philadelphia chromosome-negative myeloproliferative neoplasm in a tertiary institute in India: An ambispective study. Journal of Clinical Oncology 37 (15_suppl), e18553-e185532019

  • M Sharma, Gogia A, SVS Deo, NK Shukla, S Thulkar, R Kumar, D SharmaProfile of metastatic breast carcinoma: Single center experience from a developing country. Journal of Clinical Oncology 36 (15_suppl), e13102-e13102……2018

  • M Sharma, Gogia A, SVS Deo, NK Shukla, D Sharma, S Thulkar, R KumarEstrogen receptor (ER), progesterone receptor (PR) and Her2neu receptor expresssion: Change from baseline to first metastasis in breast cancer—Single center experience from … Journal of Clinical Oncology 36 (15_suppl), e13095-e1309, 2018

  • SK Paikaray, Gogia A, L Kumar, A Sharma, A Biswas, MC SharmaA phase III open label randomized study to compare the efficacy of lenalidomide-rituximab vs bendamustine-rituximab in treatment naive follicular lymphoma. Journal of Clinical Oncology 36 (15_suppl), e19552-e19552…….2018

  • A Biswas, L Kashyap, N Adhikari, Gogia A, R Sahoo, A Sharma. Secondary central nervous system lymphoma clinical experience from a regional cancer centre in India. Radiotherapy and Oncology 127, S692…2018

  • L Rani, M Dahiya, N Mathur, R Gupta, Gogia A, L Kumar, A Sharma.Detection of genetic aberrations in CLL using multiplex ligation-dependent probe amplification (MLPA).Leukemia & Lymphoma 58, 176-177..2017

  • Bilateral Breast Cancer-Incidence, Clinical Spectrum And Challenges In The Management. SVS Deo, NK Shukla, Gogia A. Journal of Cancer Research & Therapeutics 13. 2017

  • Criteria For Pathological Complete Response (Pcr) Cr And Its Impact On Relapse Rates In Breast Cancer Patients Undergoing Neo-Adjuvant Chemotherapy- SVS Deo, NK Shukla, Gogia A. Journal of Cancer Research & Therapeutics 13. 2017

  • Elucidation of miRNAs associated with disease progression and response in chronic lymphocytic leukemia L Rani, R Gupta, N Mathur, K Singh, Gogia A, D Sundar, L Kumar, et.al. LEUKEMIA & LYMPHOMA 58, 173-174….2017

  • Patterns of Loco-Regional Relapse in Curatively Treated Locally Advanced Breast Cancer (LABC) Patients: A Single Centre Retrospective Study. A Jakhetiya, SS Deo, NK Shukla, Gogia A, D Sharma, D Muduly, S Mathur et.al.  Annals Of Surgical Oncology 24, S50-S50…2017

  • VG Gupta, Gogia A, P Mehta, L Kumar, A Sharma, S Bakhshi, S Thulkar.Early stage natural killer/T cell lymphoma with local tumor invasiveness treated with a uniform SMILE protocol: An institutional study from India. Annals of Oncology 27 (suppl_9)..2016

  • A prospective study comparing conventional investigation and PET-CT scan for staging in locally advanced breast carcinoma. S Bhoriwal, S Deo, R Kumar, NK Shukla, S Thulkar, Gogia A, DN Sharma, et.al. European journal of Surgical Oncology Volume 42,Issue 42, Issue 9, Pages S138

  • Bone marrow involvement in mantle cell lymphoma: An immunophenotyping analysis with clinicopathologic correlation from a tertiary care center in North India. CK Das, L Kumar, Gogia A, R Kaushal. European Journal of Surgical Oncology 42 (9), S138..2016

  • Role of 18F-FDG PET/CT in the management of patients with primary breast lymphoma. S Taywade, R Kumar, A Behera, N Damle, M Tripathi, Gogia A, CS Bal. Journal of Clinical Oncology 34 (15_suppl), e19073-e19073

  • Autologous stem cell Transplantation (ASCT) for Multiple Myeloma (MM): Predictors of long term outcome. L Kumar, RR Boya, R Pai, B Sainath, RK Sahoo, PS Malik, A Mookerjee, Gogia A. Journal of Nuclear Medicine 57 (supplement 2), 1623-1623…2016

  • Non-Hodgkin lymphoma unclassifiable between diffuse large B-cell lymphoma and Burkitt lymphoma. A Singh, S Purkait, Gogia A, S Mallick. Clinical Lymphoma, Myeloma and Leukemia 15, e146-e147

  • R Gupta, L Rani, N Mathur, Gogia A, D Sundar, A Sharma, L Kumar. Impact of DNA methylation and gene expression profile on treatment initiation and treatment free survival in early stage CLL.Clinical Lymphoma, Myeloma and Leukemia 15, e145-e146

  • RR Boya, S Bakhshi, Gogia A, RK Sahoo, L Kumar. Prediction of poor mobilization of Peripheral Blood Stem Cells (PBSC) with G-CSF alone, in multiple myeloma (MM) patients undergoing autologous transplantation.Clinical Lymphoma, Myeloma and Leukemia 15, 171-72

  • Nasal NK-T cell lymphoma: 10-year experience of a single institute in India. P Mehta, V Raina, L Kumar, A Sharma, S Bakhshi, Gogia A, T Tvsvgk. Journal of Clinical Oncology 32 (15_suppl), 19536

  • VinodRaina, Gogia A, B. K. Mohanti, S. V. S. Deo, N. K. Shukla, Vishnu kumarSreenivas Breast cancer in the young (≤35 years): A single center study from the All India Institute of Medical Sciences. Journal of Clinical Oncology 31,no.15_suppl10.1200/jco.2013.31.15_suppl.e12539

  • Clinico‐Pathological Profile And Cmyc Immunoreactivity Of Alk Positive Large B Cell Lymphoma: Report Of Nine CasesS Mallick, MR Lone, P Ramteke, S Purokait, Gogia A. Hematological Oncology Volume 35, Issue S2,Page 395-6

  • Impact of DNA methylation and gene expression profile on treatment initiation and treatment free survival in early stage CLL.Ritu Gupta, Lata Rani, NitinMathur, Gogia A,DuraiSundar, Atul Sharma, Lalit Kumar. Journal of Clinical Oncology 33 (15_suppl), e22073- e22073

  • SK Bhoriwal, SVS Deo, NK Shukla, P Garg, R Kumar, Gogia A, DN Sharma, S Thulkar, S Mathur. 18FDG PET-CT–SUV correlation with molecular subtypes in locally advanced/recurrent breast carcinoma Hematological Oncology Volume 35, Issue S2, Pages, 395-396

  • Pankaj Kumar Garg, SV SuryanarayanaDeo, Rakesh Kumar, Nootan Kumar Shukla, Sanjay Thulkar, Gogia A, Dayanand Sharma, Sandeep R Mathur. Role of FDG PET–CT (Positron Emission Tomography and Computed Tomography) scan in the staging of locally advanced/recurrent breast cancer as a single modality.. Journal of Clinical Oncology Volume 33 e11508Publisher American Society of Clinical Oncology

  • CK Das, A Garg, Gogia A. 533P Docetaxel induced cutaneous toxicity in breast cancer patients.Annals of Oncology Volume 27Issuesuppl_9 …2016

  • Prashant Mehta, VinodRaina, Lalit Kumar, Atul Sharma, Sameer Bakhshi, Gogia A,TilakTvsvgk, BivasBiswas, SiddharthSahai, Surendra Pal Chaudhary, Vijay Murugan, Mehar C Sharma, SandeepMathur, Sanjay Thulkar. Nasal NK-T cell lymphoma: 10-year experience of a single institute in India.Journal of Clinical Oncology Volume 32Issue 15_suppl Pages e19536 Publisher American Society of Clinical Oncology

·        C.K. Das, A. GogiaN.K. ShuklaS. DeoS. MathurD. SharmaPrognostic significance of the derived neutrophil lymphocyte ratio in metastatic breast cancer: A tertiary cancer care center analysis from India. Annals of Oncology, Volume 27, Issue suppl_9, 1 December 2016, mdw577.005,

  • Natarajan H, Lalit Kumar, Sameer Bakhshi, Atul Sharma, Madhulika K, Velpandian T, Gogia A, ShivaramShastri, Yogendra Kumar Gupta. Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in patients with chronic myeloid leukemia.Cancer Research Volume76 Issue14 Supplement Pages2040-2040 Publisher American Association for Cancer Research

  • Reddy R, Sharma A, Bakhshi S, Gogia A, Sahoo R, Yadav CP, Kumar L. Comparison of three leukapharesis machines for harvest of stem cells for autologous transplantation: A prospective study.Journal Of Clinical Oncology 34(15_Suppl) 8024

  • H Natarajan, L Kumar, S Bakhshi, A Sharma, T Velpandian,Gogia A, YK Gupta. Imatinib trough levels: A potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia. Annals of Oncology Volume 27 Issue suppl_9 Page 586

  • P Mehta, L Kumar, V Raina, A Sharma, S Bakhshi, Gogia A, RK Sahoo, S Pabbi, A Chopra, R Kumar high dose (18 g/m) versus low dose (12 g/m) cytosine arabinoside as consolidation for acute myeloid leukemia. Annals of Oncology 26,85

  • CK Das, L Kumar, SR Mallick, Gogia A. Prognostic significance of monocyte-lymphocyte ratio in mantle cell lymphoma.Annals of Oncology.2015; Volume 26 Issue suppl_9

  • Ritu Gupta, Lata Rani, NitinMathur, Gogia A,SreenivasVishnubhatla, Lalit Kumar, Atul Sharma, DivyaDubey, PunitKaur. Analysis of IGHV-DJ gene rearrangement and B-cell receptor stereotypes in chronic lymphocytic leukemia: an Indian study. Leukemia & Lymphoma.2015; Volume 56 Pages 124-125

  • R Upadhyay, DN Sharma, AK Gandhi, K Haresh, S Deo, Gogia A. Role of radiation therapy and its impact on survival of male breast cancer patients: experience from a tertiary cancer center. International Journal of radiation Oncology.biology.Physics.2016; 96(2)E 29

  • R Reddy, S Bakhshi, A Sharma, R Sahoo, Gogia A, PS Malik, S Iqbal, Poor mobilization of peipheral blood stem cells (PBSC) in patients undergoing autologous stem cell transplantation (ASCT): A prospective study.ClinicalLymphoma, Myeloma and Leukemia.2015; 15, e 171

  • S Gajendra, A Chopra, S Kumar, Gogia A, J Chandramohan, S Bakhshi.Immunophenotypic analysis of T-lineage acute lymphoblastic leukemia. CD5 matters.... International Journal of Radiation Oncology.2016;• Biology• Physics 96 (2), E29

  • L Kumar, P Ganess, Gogia A, I Ghosh, R Hariprasad. High Dose Chemotherapy With Autologous Stem Cell Transplantation For Multiple Myeloma: What Predicts The Outcome? Journal of Clinical Oncology.2015; 33 (15_suppl), e18013-e18013

  • Gogia A, V Raina , Sharma MC .Survival outcome of patient with primary gastric diffuse large B-cell lymphoma: An Institutional experience from developing country.Annals of Oncology 2014 Volume26 Issue suppl 4

  • Gogia A, V Raina, A Sharma, L Kumar, R Gupta, MC Sharma Incidence of second cancer in patients with chronic lymphocytic leukemia: 13 years experience from single institute.European Journal Of Cancer.2013; 49, S846-S846

  • Gogia A, V Raina, A Sharma, L Kumar, R Gupta, S Gajendra, Significance of smudge cell on blood smear in chronic lymphocytic leukemia patients: A prospective single institutional study from India.European Journal Of Cancer.2013; 49, S207-S208

  • A.Gogia, A. Sharma, V. Raina, L. Kumar, R. Kumar, R. Gupta.Clinico-hematological characteristics and outcome assessment of patients with chronic lymphocytic leukemia: A single-institution study of 285 cases.DOI: 10.1200/jco.2011.29.15_suppl.6584 Journal of Clinical Oncology 29, no. 15_suppl (May 2011) 6584-6584

  • Gogia A, Vinod Raina, Atul Sharma, Lalit Kumar, Mehar C Sharma, Ritu Gupta, Prasenjit Das.Clinical features and outcome of follicular lymphoma: 17 years experience from All-India Institute of Medical Sciences (AIIMS), New Delhi, India. Journal of Clinical Oncology Volume31 Issue15_suppl Pages e19524-e19524 American Society of Clinical Oncology 2012

  • Gogia A, V Raina, BK Mohanti, SVS Deo, NK Shukla, V Sreeniwas.Clinical significance of triple negativity in young breast cancer patients (<= 35 years): A single-institute study from India.European Journal Of Cancer 49, S315-S315 2013

  • Gogia A, V Raina, B Mohanti, S Deo, N Shukla Pattern and Survival of Lung Metastasis In Young Breast Cancer Patients: A Single Centre Experience Publication date2013/5/1. Journal Lung Cancer, Volume80,PagesS41, DBT -Travel Grant,Wclc, Sydney, Australia,2014

  • Gogia A, V Raina, SVS Deo, BK Mohanti, NK Shukla, S Venkat. An overview of very young breast cancer patients. The Breast, Volume21, PagesS15,SIOP-Travel Scholarship,Dublin 2018

  • Gogia A, V Raina, SVS Deo, BK Mohanti, NK Shukla. Profile Of Male Breast Cancer: Single Institution Study Of 76 Patients from Northern India. Annals Of Oncology, Volume23, Pages110-110, young investigator award,Saintgallen Breast Cancer Conferance 2013.

  • Gogia A, A Sharma, V Raina, L Kumar, R Gupta, R Kumar. An Overview Of Young Chronic Lymphocytic Leukemia Patients: A Single Centre Experience Of 117 Cases From Northern India Annals Of Oncology, Volume 23, Pages 358-358, ICMR-TRAVEL GRANT,ESMO-2013,Amsterdam.

  • A Mittal, Svs Deo, Gogia A, A Batra, A Kumar, S Bhoriwal, KS Deb.ASO Visual Abstract: Profile Of Pathogenic Mutations And Evaluation Of Germline Genetic Testing Criteria In Consecutive Breast Cancer Patients Treated At A North Indian, Annals Of Surgical Oncology. 2022; 29 (2), 1435-1436

  • S Roy, A Biswas, A Binjola, M Tripathi, R Kumar, S Bakhshi, R Sahoo,Gogia A.Early Clinical Outcome, Acute Toxicity Profile And Health Related Quality Of Life After Chemo-Immunotherapy And Involved Site Radiotherapy (ISRT) In Early Nodal DLBCL-Results ..,International Journal Of Radiation Oncology, Biology, Physics.2020; 108 (3), S156-S157

  • S Jain, S Mallick, P Ramteke, Gogia A, M Agarwal, J Dass, R Yadav. Pandora Box Of Lymphomas In Spleen. ...Hematology Reports.2020; 12 (s1)

  • S Jain, A Goswami, P Ramteke, Mc Sharma, Gogia A, A Sharma. Tcl-362: Clinicopathological Profile Of Peripheral T-Cell Lymphoma-Nos And Angioimmunoblastic T-Cell Lymphomas., ...Clinical Lymphoma, Myeloma And Leukemia.2020; 20, S256-S257

  • Ck Das, Gogia A, L Kumar, A Sharma, S Thulkar, I Xess, K Madan. Evaluation Of Pulmonary Infiltrate In Febrile Neutropenic Patients Of Hematologic Malignancies. Indian Journal Of Medical And Paediatric Oncology.2019; 40 (03), 386-390

  • R Pramanik, H Kancharla, S Bakhshi, A Sharma, Gogia A, P Malik.Engraftment Syndrome: A Retrospective analysis of the experience at atertiary care Institute,Clinical Hematology International.2019; 1 (2), 114

  • M Sharma, Gogia A, Svs Deo, S Thulkar, RkPhulia, Ps Malik, S Mathur. Prognostic And Predictive Factors of Outcome In Metastatic Breast Cancer In India: Experience From A Dedicated Breast Cancer Clinic Of A Tertiary Health Care Center. The Breast.2019; 44, S61

  • Gogia A, V Raina, S Deo, D Sharma, S Mathur. Survival Outcome Of Pregnancy Associated Breast Cancer In Resource Limited Country: An Analysis. The Breast.2019; 44, S64

  • Gogia A, S Deo, S Mathur, D Sharma, R Gupta. Predictive Significance Of Derived Neutrophil To Lymphocyte Ratio With Neo-Adjuvant Chemotherapy In Triple Negative Breast Cancer: A Single Center Analysis. The Breast.2019; 44, S26

  • Gogia A, V Raina, S Deo, N Shukla, B Mohanti, D Sharma, S Mathur. Neoadjuvant Chemotherapy For Young (</= 35 Years) Locally Advanced Breast Cancer Patients: Association Of Pathological Complete Response With Survival. An Institutional … The Breast. 2019; 44, S128

  • M Sharma, Gogia A, Svs Deo, S Thulkar, RkPhulia, Ps Malik, S Mathur. Oligo-Metastatic Breast Cancer: Real World Scenario From A Single Center In India. The Breast. 2019; 44, S60

  • R Singh, S Kumar, Gogia A, D Sharma, S Deo. Impact Of Tumor Size On Prediction Of Pathological Complete Response After Neoadjuvant Chemotherapy In Breast Cancer. The Breast. 2019; 44, S70-S71

  • R Singh, S Bhoriwal, Gogia A, D Sharma, S Deo. Routine Cavity Shave During Breast Conservation Surgery Is A Good Alternative To Frozen Sections. The Breast. 2019; 44, S110-S111

  • A Biswas, N Adhikari, Gogia A, R Sahoo, A Garg, M Sharma, S Bhasker. High Dose Methotrexate Based Chemotherapy And Response Adapted Whole Brain Radiation Therapy In Primary Cns Lymphoma...International Journal Of Radiation Oncology, Biology, Physics. 2018; 102 (3), S192

  • N Adhikari, A Biswas, Gogia A. A Phase II Trial Of Response Adapted Whole Brain Radiotherapy After High Dose Methotrexate Based Chemotherapy In Patients With Newly Diagnosed Primary Central Nervous System … Annals Of Oncology. 2018; 29, Ix22

  • R Sahoo, M Patekar, N Adhikari, A Biswas, V Raina, L Kumar, A Sharma,Gogia A.Primary Central Nervous System Lymphoma In India: A 17-Year Experience From Aiims. ...Clinical Lymphoma, Myeloma And Leukemia. 2018; 18, S286

  • S Mallick, Mr Lone, P Ramteke, S Purokait, Gogia A, A Batra, S Bakhshi. Clinico‐Pathological Profile AndCmyc Immunoreactivity Of Alk Positive Large B Cell Lymphoma: Report Of Nine Cases. ...Hematological Oncology. 2017; 35, 395-396

  • V Ramalingam, S Hari, Sb Paul, S Thulkar, S Vyas, Gogia A, Svs Deo. Assessment Of Response To Neo-Adjuvant Chemotherapy In Breast Carcinoma Using Shear Wave Elastography., ...European Congress Of Radiology-2017; Ecr 2017

  • Ck Das, Gogia A, Nk Shukla, S Deo, S Mathur, D Sharma. 121p Prognostic Significance Of The Derived Neutrophil Lymphocyte Ratio In Metastatic Breast Cancer: A Tertiary Cancer Care Center Analysis From India. Annals Of Oncology. 2016; 27, Ix36

  • Gogia A, V Raina. An Update Analysis Of Rituximab Based Chemotherapy In Chronic Lymphocytic Leukaemia Patients: An Indian Scenario. Haematologica. 2014; 99, 585-585

  • Gogia A, V Raina, A Sharma, L Kumar, R Gupta, S Vishnubhatla. Smudge Cells On Routine Blood Smear Predict Clinical Outcome In Chronic Lymphocytic Leukemia: An Institutional Study., ...Leukemia & Lymphoma. 2013; 54, 5-6

  • Gogia A, V Raina, S Deo, B Mohanti, N Shukla. An Overview of Male Breast Cancer: 17 Years experience From A Single Centre. Breast. 2013; 22, S47-S47

  • R Upadhyay, DN Sharma, AK Gandhi, K Haresh, S Deo, Gogia A.Role of radiation therapy and its impact on survival of male breast cancer patients: experience from a tertiary cancer center. …International Journal of Radiation Oncology, Biology, Physics. 2016; 96 (2), E29

  • N Harivenkatesh,L Kumar, S Bakshi, A Sharma, M Kabra, T Velpandian, Gogia A.Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in patients with chronic myeloid leukemia. - Cancer Research. 2016; 76 (14 Supplement), 2040-2040

  • Gogia A, V Raina, A Sharma, L Kumar. Safety and efficacy of rituximab based chemotherapy in chronic lymphocytic leukaemia patients: A single centre experience. European Journal of Cancer. 2013; 49, S844-S845

  • V Raina, Gogia A, SVS Deo, BK Mohanti, NK Shukla. Clinico-Pathological Characteristics and Treatment Outcome of Young Breast Cancer Patients: an Institutional Study. Annals of Oncology. 2017; 23

  • H Imran, T Pranay, S. V. S. Deo, Gogia A. A study of PIK3CA gene mutation and its association with hormone receptor positive and HER2 receptor negative in breast cancer patients". Conference Paper. October 2017. 1st Annual Indian Breast Cancer Conference

  • Gogia A, Raina V, Sharma M. P-122Primary gastric diffuse large B cell lymphoma: A single center experience from developing country. June 2018. Annals of Oncology

 

BOOK CHAPTERS (3) 

  • Hormone-dependent Malignancies in Elderly: Endometrium, Breast and Prostate, Text book of Geriatric Medicine

  • Role of Autologous Transplant in hematological Malignancies, Recent Advance in Hematology

  • Basics of Cancer Biology and Therapy: Update in Onco-Anaesthesia

 

 Accepted for Publication : Pending in Press original article( corresponding):

  • "Dose-dense neoadjuvant chemotherapy in triple-negative breast cancer: Real world data from a developing country", is accepted for publication in the journal. (ijc_1120_21) Indian Journal of cancer  (Indian Journal of cancer)

  • A phase III open label randomized study to compare the efficacy of Lenalidomide-Rituximab vs Bendamustine-Rituximab in treatment naïve Follicular Lymphoma'. IJC_320_20

Correspondance: corresponding author

crst_241_22 Triplet therapy, transplantation and maintenance until progression in myeloma

crst_218_22 Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma

crst_217_22 Trastuzumab Deruxtecan in HER2-low Breast Cancer

crst_216_22 Neoadjuvant nivolumab with chemotherapy in resectable lung cancer

 

ABSTRACTS: (first author)

ABCL-200 Primary and Secondary Extranodal Diffuse Large B-Cell Lymphoma: A Single-Center Survey from India (journal : Clinical Lymphoma Myeloma and Leukemia)

 

ABCL-398 Primary Breast Diffuse Large B-cell Lymphoma: An Indian Experience 

(journal : Clinical Lymphoma Myeloma and Leukemia)

 

ABCL-400 Adult Burkitt Lymphoma: An Institutional Experience with Uniform DA-EPOCH-R Protocol 

(journal : Clinical Lymphoma Myeloma and Leukemia)

 

AML-194 Second Hematological Malignancies in Survivors of Breast Cancer: An Indian Institutional Analysis

(journal : Clinical Lymphoma Myeloma and Leukemia)

  

IBCL-429 Prevalence of B-Cell Chronic Lymphoproliferative Disorders at a Large Tertiary Care Center in India (journal : Clinical Lymphoma Myeloma and Leukemia) 

 

Photo gallery ( International  Fellowship)

Article in India Today Magazine ( Nov 21, 2016)

 

Photo gallery ( FREE MEDICAL CAMP AT LEH AND DHARAMSHALA)

 

 

Zo2 Framework Settings

Select one of sample color schemes

Google Font

Menu Font
Body Font
Heading Font

Body

Background Color
Text Color
Link Color
Background Image

Header Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Menu Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Main Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Inset Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Bottom Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image
Background Color
Modules Title
Text Color
Link Color
Background Image
 
Top of Page
BCMath lib not installed. RSA encryption unavailable